Watson Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?
WATSON LABS has one thousand and thirty-two approved drugs.
There are eighteen tentative approvals on WATSON LABS drugs.
Drugs and US Patents for Watson Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | IBUPROFEN | ibuprofen | TABLET;ORAL | 071905-001 | Mar 8, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 076933-002 | Aug 10, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs Inc | DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 075426-002 | Oct 18, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs | TEMAZEPAM | temazepam | CAPSULE;ORAL | 070384-001 | Mar 23, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs | CHLOROTHIAZIDE W/ RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 088151-001 | Jun 9, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for WATSON LABS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
Similar Applicant Names
Here is a list of applicants with similar names.